Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
about
Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult WormsStudy of the electrospray ionization mass spectrometry of the proton pump inhibiting drug Omeprazole.Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.SuperToxic: a comprehensive database of toxic compoundsThe expression of heme oxygenase-1 induced by lansoprazole.Synthesis, characterisation and evaluation of N-mannich bases of 2-substituted Benzimidazole derivatives.Esomeprazole: potent acid suppression in the treatment of acid-related disorders.Synthesis and antinociceptive activity of novel mannich base derivatives of some new fused 3,5-pyrazolidinedione.Oesophageal lumen pH in yearling horses and effects of management and administration of omeprazole.Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.Solubility of Omeprazole Sulfide in Different Solvents at the Range of 280.35-319.65 K.Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.Omeprazole-induced dermatomyositis.Synthesis and Analgesic Activity of Novel Derivatives of 1,2-Substituted Benzimidazoles
P2860
Q28548401-0AF6A7F0-8808-404E-809A-6AEEAD58FAC5Q32063658-63D6775A-A7D0-4FAB-B655-1E2AFC5B1F0EQ34181922-1705910A-E29B-4905-B08A-77B3E62DE643Q34284529-D6F5E329-EAB4-4C3F-A43F-094E70F0061EQ37202625-7EEE893F-5B53-467E-88A5-FC7B3B04777BQ37546869-FB427529-0CEE-4600-822A-0F78FB92C75FQ37594815-F325C831-33F5-4D96-A83C-54294F0B3D6FQ37755220-9683EE53-DFE5-42D4-8505-871A5DFA798DQ38368201-AFE6A73D-6D58-45C8-8553-1CE524114367Q39627561-6D1A2057-D9F7-4582-8721-480BB9911F95Q41883446-6409B31D-CB53-456D-BBF5-1F79F5DAD37FQ41897025-D08C20C4-E8B8-4874-9CDE-77363E6B38EBQ41905895-5AD35E22-221D-4044-8C4C-DE00518603E2Q43591822-DD354669-6C50-42CE-A35C-63948411E587Q46674913-FA19A881-6E3D-4BF9-8DE1-5244CF36DE7EQ46918576-953A5D2A-FA47-48C9-A2DC-2676F1633E0EQ59010708-CC997DBF-60E4-4A0A-9271-FB6CD06E142C
P2860
Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@ast
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@en
type
label
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@ast
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@en
prefLabel
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@ast
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@en
P1433
P1476
Omeprazole. A review of its us ...... oidal anti-inflammatory drugs.
@en
P2093
H D Langtry
P304
P356
10.2165/00003495-199856030-00012
P577
1998-09-01T00:00:00Z
P6179
1015288308